Molekule Group, Inc.

OTCPK:MKUL.Q Stock Report

Market Cap: US$15.3k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Molekule Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Molekule Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Building earnings growth20.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article • Oct 18

Companies Like AeroClean Technologies (NASDAQ:AERC) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Seeking Alpha • Aug 16

AeroClean Technologies GAAP EPS of -$0.37, revenue of $70.92K

AeroClean Technologies press release (NASDAQ:AERC): Q2 GAAP EPS of -$0.37. Revenue of $70.92K.
Seeking Alpha • Jun 16

AeroClean: Beneficial News From The FDA, But There Are Too Many Risks

AeroClean offers interior space air purification technology to fight harmful airborne pathogens in the medical industry. I am right now talking about AeroClean because very recently management announced that the FDA had officially classified AeroClean’s Pūrgo technology as a class II medical device. The company already noted that the ongoing global logistics and supply chain bottlenecks could harm the production of new devices.
Seeking Alpha • Dec 19

AeroClean Technologies: Proprietary Portable Air Sanitization Devices

AeroClean Technologies has developed proprietary air sanitization devices using patented technologies for enclosed spaces and lifts. The Company’s product is allowed to be marketed and sold in public health emergency situations and is anticipated to get full FDA 510k clearance by 2H-2022. The Company started recognizing revenue since July 2021, and expects it to rise significantly in 2022.

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Molekule Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:MKUL.Q - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202322-33-35-34N/A
3/31/20239-14-25-25N/A
12/31/20220-6-11-11N/A
9/30/20220-3-10-10N/A
6/30/20221-11-8-8N/A
3/31/20221-9-9-8N/A
12/31/20211-8-10-8N/A
9/30/20210-8-9-7N/A
6/30/2021N/A-8-9-7N/A
3/31/2021N/A-5-6-5N/A
12/31/2020N/A-3-4-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MKUL.Q's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if MKUL.Q's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if MKUL.Q's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MKUL.Q's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if MKUL.Q's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MKUL.Q's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/04 23:10
End of Day Share Price 2024/03/01 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Molekule Group, Inc. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company